Nosological Tunnel Vision in Biological Psychiatry: A Plea for a Functional Psychopathology

Annals of the New York Academy of Sciences

Volumn 600, Issue 1, 1990, Pages 501-510

  VAN PRAAG, H M ^a   ASNIS, G M ^a   KAHN, R S ^a   BROWN, S L ^a   KORN, M ^a   FRIEDMAN, J M HARKAVY ^a   WETZLER, S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; HYDROCORTISONE;

ANXIETY; BIOLOGICAL MODEL; CONFERENCE PAPER; DEPRESSION; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; VISION;

5-HYDROXYTRYPTOPHAN; AGGRESSION; BIOLOGY; DEPRESSION; DEPRESSIVE DISORDER; HUMAN; MENTAL DISORDERS; PSYCHIATRY; SEROTONIN;

NEOPLEA;

EID: 0025682974     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1990.tb16905.x     Document Type: Article

References (44)

1. Neubewertung des syndroms
2. Dopamine metabolism in depression, psychoses, and parkinson's diesase: The problem of the specificity of biological variables in behaviour disorders
3. Denosologization of biological psychiatry on the specificity of 5‐HT disturbances in psychiatric disorders
4. Beyond serotonin. A multi‐aminergic perspective on abnormal behavior
5. 5‐hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid
6. The monoamine hypothesis of depression: The case for serotonin
7. Neurotransmitters and CNS disease: Depression
8. 5 hydroxytryptamine and depression: A model for the interaction of normal variances and pathology
9. Endogenous depressions with and without disturbances in the 5‐hydroxytryptamine metabolism: A biochemical classification?
10. Monoamine precursors in the treatment of psychiatric disorders
11. In search of the mode of action of antidepressants: 5‐HT‐tryosine mixtures in depressions
12. 1987b. Hormonal probes of central serotonergic activity
13. Serotonin precursors with and without tyrosine in the treatment of depression
14. Differential behavioral effects of tryptophan and 5‐hydroxytryptophan in vervet monkeys: Influence of catecholaminergic systems
15. 5‐HIAA in the cerebrospinal fluid: A biochemical suicide predictor?
16. Biological suicide research. Outcome and limitations
17. Aggression in humans correlates with cerebrospinal fluid metabolites
18. Aggression, suicide and serotonin: Relationships to CSF amine metabolites
19. Serotonergic functions in the 47, XYZ syndrome
20. Low cerebrospinal fluid 5‐hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior
21. 5‐Hydroxyindoleacetic acid in attempted suicides who have killed their children
22. Homicide, suicide and CSF 5‐HIAA
23. Cerebrospinal fluid monoamine metabolite levels in male arsonists
24. Correlates of suicide and violence risk, III. A 2‐stage model of countervailing forces
25. The serotonin‐hypothesis of (auto) aggression. Critical appraisal of the evidence
26. The treatment of phobic anxiety by zimeldine
27. A pilot study of the effect of the 5‐HT uptake inhibitor, zimelidine, on phobic anxiety
28. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks
29. Zimelidine treatment of obsessive‐compulsive disorder
30. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: A double‐blind comparison of 5‐hydroxytryptophan, clomipramine and placebo
31. Effect of serotonin uptake inhibitors in anxiety disorders: a double‐blind comparison of clomipramine and fluvoxamine
32. l‐5‐Hydroxytryptophan in the treatment of anxiety disorders
33. Serotonin and anxiety revisited
34. Behavioral indications for receptor hypersensitivity in panic disorder
35. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder
36. Pharmacological and clinical effects of buspirone
37. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: A double‐blind placebo‐controlled study versus lorazepam
38. The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist
39. Correlation between CSF metabolites and psychomotor activity in affective disorders
40. Rorschach ratings in depressed and suicidal patients with low CSF 5‐HIAA
41. The relationships between a serotonergically linked series of psychopathological dimensions
42. 1987c
43. Monoamines and abnormal behavior. A multiaminergic perspective